HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/4/R1111    most recent 00396.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Houmard, J. A. Search for Related Content PubMed PubMed Citation Articles by Houmard, J. A.

INVITED REVIEW

CALL FOR PAPERS
Insulin Resistance and the Cardiometabolic Syndrome: Adipose Tissue and Skeletal Muscle Factors

Intramuscular lipid oxidation and obesity

Human Performance Laboratory, Department of Exercise and Sport Science, East Carolina University, Greenville, North Carolina

There is an accumulating amount of evidence indicating that lipid oxidation is depressed in the skeletal muscle of obese individuals. Decrements in fatty acid oxidation (FAO) have been reported with obesity in models ranging from whole body measurements to isolated skeletal muscle preparations as well as in myotubes raised in culture. This reduction appears to be associated with a depression in the activities of enzymes involved in various steps of lipid oxidation, which subsequently partitions lipid entering the cell toward storage. The defect in FAO in skeletal muscle may be critical in relation to health, as a reduction in the capacity for lipid oxidation could directly or indirectly contribute to the insulin resistance commonly evident with obesity. Although less characterized, a decrement in FAO has also been linked with weight gain, which suggests that this characteristic may be an integral aspect leading to the obese state. In terms of intervention, weight loss does not seem to correct the defect in FAO with obesity. This review will provide evidence supporting a reduction in muscle FAO with obesity.

skeletal muscle; metabolism; insulin action

This article has been cited by other articles:

				H. Alkhateeb, A. Chabowski, J. F. C. Glatz, B. Gurd, J. J. F. P. Luiken, and A. Bonen Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1056 - E1066. [Abstract] [Full Text] [PDF]

				E. Ehrenborg and A. Krook Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor {delta} Pharmacol. Rev., September 1, 2009; 61(3): 373 - 393. [Abstract] [Full Text] [PDF]

				J. G. Nickerson, H. Alkhateeb, C. R. Benton, J. Lally, J. Nickerson, X.-X. Han, M. H. Wilson, S. S. Jain, L. A. Snook, J. F. C. Glatz, et al. Greater Transport Efficiencies of the Membrane Fatty Acid Transporters FAT/CD36 and FATP4 Compared with FABPpm and FATP1 and Differential Effects on Fatty Acid Esterification and Oxidation in Rat Skeletal Muscle J. Biol. Chem., June 12, 2009; 284(24): 16522 - 16530. [Abstract] [Full Text] [PDF]

				A. Lombardi, P. de Lange, E. Silvestri, R. A. Busiello, A. Lanni, F. Goglia, and M. Moreno 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E497 - E502. [Abstract] [Full Text] [PDF]

				M. J. Laye, R. S. Rector, S. J. Borengasser, S. P. Naples, G. M. Uptergrove, J. A. Ibdah, F. W. Booth, and J. P. Thyfault Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue J Appl Physiol, January 1, 2009; 106(1): 161 - 168. [Abstract] [Full Text] [PDF]